Skip to main content
    D

    Daxor Corporation (DXR)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ

    $8.29
    -0.19 (-2.24%)

    Market Cap: $49.51M

    Last updated: Nov 17, 2026 at 10:57 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    67%(2/3)
    Avg Surprise
    -109.67%
    Streak
    1 Q

    Upcoming Estimates

    Results pendingPeriod ending Jun 30, 2026
    EPS Consensus-$0.06
    Range-$0.06 - -$0.06
    1 analysts
    EPS Revisions
    0
    1
    30d
    EPS Estimate DriftChange to current
    90d ago-$0.03-100.0%
    60d ago-$0.03-100.0%
    30d ago-$0.03-100.0%
    7d ago-$0.03-100.0%
    Current-$0.06
    Revenue Consensus
    $2.00M
    Range$2.00M - $2.00M
    1 analysts
    Last 12 of 33 reported quarters and 1 upcoming estimate
    PeriodReportedEst.RangeSurpriseB/MAnalystsRevisionsYoY
    Jun 26EST
    Date TBD
    --$0.06-$0.06 - -$0.06--1
    0
    1
    30d
    -
    Jun 25
    Reported Aug 29
    -$0.07N/AN/A-----
    Mar 25
    Reported May 13
    Not reportedN/AN/A-----
    Dec 24
    Reported Mar 6
    $0.43N/AN/A-----
    Sep 24
    Reported Nov 29
    Not reportedN/AN/A-----
    Jun 24
    Reported Aug 22
    Not reportedN/AN/A-----
    Mar 24
    Reported Jun 28
    Not reportedN/AN/A-----
    Dec 23
    Reported Mar 24
    Not reportedN/AN/A--0
    No revisions (30d)
    -
    Sep 23
    Reported Nov 9
    Not reportedN/AN/A--0
    No revisions (30d)
    -
    Jun 23
    Reported Aug 28
    Not reportedN/AN/A--0
    No revisions (30d)
    -
    Mar 23
    Reported May 9
    Not reportedN/AN/A--0
    No revisions (30d)
    -
    Dec 22
    Reported Mar 1
    $1.54N/AN/A--0
    No revisions (30d)
    -1.3%
    Sep 22
    Reported Nov 10
    Not reportedN/AN/A--0
    No revisions (30d)
    -

    Dividends

    Last ex-dividend: Jan 5, 2018

    Dividend Metrics

    Forward Yield0.00%
    Forward Annual Dividend$0.00
    Payout Ratio0.00%
    FrequencyAnnual
    No dividend payments in the selected period.

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin19861.00%Operating Margin-5894.00%
    ROE14.20%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest Coverage7.30x
    Current RatioN/AQuick RatioN/A
    Trading Statistics
    Beta0.44Avg Volume12.07K
    52-Week High$14.7652-Week Low$8.24

    Technical Indicators Dashboard

    As of Nov 16, 2026, the price is 17.7% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 30.4, in the neutral range between 30 and 70.

    Moving Averages

    SMA 10$8.57
    SMA 20$8.90
    SMA 50$10.07
    SMA 200$10.47
    EMA 10$8.60
    EMA 20$8.95
    EMA 50$9.62
    EMA 200$10.39

    MACD

    Line: -0.46Signal: -0.47Hist: 0.00

    ADX

    ADX: 40.6+DI: 9.4-DI: 25.8

    Aroon & PSAR

    Aroon Up4.0
    Aroon Down92.0
    PSAR$8.95

    Bollinger Bands

    Upper Band$9.75
    Lower Band$8.05
    %B Position1908%(Upper)
    Band Width0.14

    RSI (14-Day)

    Neutral
    30.4

    Momentum Oscillators

    Stoch %K17.5
    Stoch %D16.6
    Williams %R-94.8
    ROC (10d)-7.9%
    Momentum-0.71
    CCI (20d)-99.5
    MFI (14d)37.6

    Volatility Measures

    ATR (14d)$0.39(4.7%)
    StdDev (20d)0.42
    Hist Vol33.4%(Moderate)

    Volume Flow

    VWAP$8.43
    OBV1.2M
    AD Line208.9K
    CMF (20d)0.004

    Volume Metrics

    Avg Vol (20d)12.3K
    Vol Ratio0.2x(Low)
    VWMA (20d)$8.92

    Pivot Points

    R3$8.84
    R2$8.71
    R1$8.60
    Pivot Point$8.47
    S1$8.36
    S2$8.23
    S3$8.12

    Advanced Oscillators

    TSI-35.49
    Ultimate Osc42.9
    KST-170.06

    Financial Performance

    Related GNG Research

    No research available

    Be the first to write about DXR

    Gov Obligations (TTM)
    $0
    Gov Obligations / Revenue
    N/A
    Obligations YoY
    N/A
    Active Awards
    1
    New Awards (TTM)
    0
    Avg Remaining Term
    24.9 mo

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    DXR Valuation

    GNG's valuation label for DXR is Undervalued. It trades at 64.5x forward earnings.

    Forward P/E
    64.5x
    P/B
    0.8x
    All DXR metrics

    DXR Profitability: Margins, ROIC and FCF

    Daxor (DXR) has a gross margin of -106.5%, an operating margin of -5894.0% and a net margin of 19861.0%. It posts a -1834.0% FCF margin.

    Gross margin
    -106.5%
    Operating margin
    -5894.0%
    Net margin
    19861.0%
    ROE
    14.2%
    FCF margin
    -1834.0%
    DXR financial statements

    Daxor Competitors

    The companies most similar to Daxor (DXR) include Harvard Bioscience, Nephros and Precision Optics Corporation, Inc. Common stock.

    Sector: Healthcare

    DXR Bull Case vs Bear Case

    Bull case

    • DXR has a 19861.0% net profit margin.
    • DXR grew quarterly revenue 25.5% year over year.

    DXR Earnings: Beat Rate

    Beat rate
    5 of 8 quarters (62.5%)
    Average surprise
    32.0%

    DXR Dividend

    Forward yield
    0.0%
    Payout ratio
    0.0%

    DXR Earnings Call

    The latest DXR earnings call transcript on file is labeled 2024Q4.

    Read the 2024Q4 transcript

    DXR ETF Holders

    See insider activity

    Updated Sep 4, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology

    Frequently Asked Questions About DXR

    Does DXR pay dividends?

    Daxor Corporation (DXR) has a dividend payment track record. See the DXR dividend history page for its current payment status, TTM yield, and recorded payments.

    What is DXR's market cap?

    Daxor Corporation (DXR) has a market capitalization of $49.51M with a current stock price of $8.29.

    Is DXR stock overvalued?

    GNG's valuation label for DXR is Undervalued. Daxor Corporation (DXR) trades at 64.5x forward earnings.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.